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Abstract
Background: In order to identify new virulence determinants in Y. pseudotuberculosis a comparison between its
genome and that of Yersinia pestis was undertaken. This reveals dozens of pseudogenes in Y. pestis, which are still
putatively functional in Y. pseudotuberculosis and may be important in the enteric lifestyle. One such gene,
YPTB1572 in the Y. pseudotuberculosis IP32953 genome sequence, encodes a protein with similarity to invasin, a
classic adhesion/invasion protein, and to intimin, the attaching and effacing protein from enteropathogenic (EPEC)
and enterohaemorraghic (EHEC) Escherichia coli.
Results: We termed YPTB1572 Ifp (Intimin family protein) and show that it is able to bind directly to human HEp-2
epithelial cells. Cysteine and tryptophan residues in the C-terminal region of intimin that are essential for function
in EPEC and EHEC are conserved in Ifp. Protein binding occurred at distinct foci on the HEp-2 cell surface and can
be disrupted by mutation of a single cysteine residue at the C-terminus of the protein. Temporal expression
analysis using lux reporter constructs revealed that ifp is expressed at late log phase at 37°C in contrast to invasin,
suggesting that Ifp is a late stage adhesin. An ifp defined mutant showed a reduction in adhesion to HEp-2 cells
and was attenuated in the Galleria mellonella infection model.
Conclusion: A new Y. pseudotuberculosis adhesin has been identified and characterised. This Ifp is a new member
in the family of invasin/intimin outer membrane adhesins.
Background
Within the genus Yersinia there are three human-patho-
genic species; Y. pestis, the causative agent of plague,
and two enteric pathogens, Y. pseudotuberculosis and Y.
enterocolitica. Despite the differences in disease, Y. pestis
and Y. pseudotuberculosis are very closely related at the
genetic level. Y. pestis is believed to have evolved from
Y. pseudotuberculosis between 1,500-20,000 years ago
[1]. Thus, in a remarkably short length of evolutionary
time, Y. pestis has evolved from an enteropathogen, to a
blood-borne pathogen with an insect vector [2]. Gen-
ome sequencing of several Y. pseudotuberculosis and Y.
pestis strains, revealed that Y. pestis has accumulated a
large number of pseudogenes since its divergence. By
the “u s ei to rl o s ei t ” paradigm, this is suggestive of the
decay of those genes that are no longer required for
function as Y. pestis adapts to a new lifestyle [3,4]. Gene
disruption may also result in pathoadaptive mutation,
whereby loss of gene function results in an increase in
virulence [5]. This has been demonstrated in several
pathogenic bacteria including Shigella spp. and Escheri-
chia coli [6,7]. Pathoadaptive mutations have previously
been identified in Y. pestis,w i t ht h en e g a t i v er e g u l a t o r s
of biofilm formation, rcsA and nghA, being disrupted,
resulting in the ability of Y. pestis to form biofilms
within the flea vector [8,9].
Pseudogenes in Y. pestis that are known to be essential
for the enteric lifestyle of Y. pseudotuberculosis,i n c l u d e
the adhesins YadA and invasin [3,10,11]. Invasin was one
of the first bacterial virulence factors identified, when it
w a so b s e r v e dt h a tt h einv gene alone was sufficient to
convert benign non-invasive laboratory E. coli strains, to
being capable of invading tissue culture cells [12]. Invasin
is a 103 kDa protein that is capable of binding to b1
integrins on the host cells, promoting internalisation of
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any medium, provided the original work is properly cited.the bacterium [13]. During early infection, invasin speci-
fically binds b1 integrins on the apical surface of M cells,
which facilitates efficient translocation to the underlying
Peyer’s patches [14]. The invasin protein is composed of
a short N-terminal transmembrane domain, four struc-
tural bacterial immunoglobulin domains (bIg domains)
and a C-type lectin-like domain [15]. The last bIg domain
and the C-type lectin-like domain comprise the func-
tional b1 integrin binding region [15,16].
I nt h es a m ef a m i l yo fb a c t e r i a la d h e s i o np r o t e i n sa s
invasin, is intimin, an important adhesin expressed by
enteropathogenic (EPEC) and enterohaemorrhagic
(EHEC) E. coli on the LEE pathogenicity island [17].
Intimin is a 94 kDa outer membrane protein that is also
found in Citrobacter freundii and Hafnia alvei [17,18].
The functional binding domain of intimin is located in
the 280 amino acid C-terminal region, and consists of
two bIg domains and a C-type lectin-like domain, which
are structurally similar to invasin [15,18,19]. When
EPEC and EHEC colonise the small intestine mucosa, a
characteristic attaching and effacing lesion is formed.
First there is localised destruction (effacement) of the
microvilli, which leads to intimate attachment of the
bacterium to the host cell [20]. EPEC and EHEC encode
a specific intimin receptor, translocated intimin receptor
(Tir). This receptor is translocated directly into the host
cells via a type III secretion system, where it becomes
expressed on the cell surface [21,22]. Intimin binds to
Tir leading to its activation, which results in actin poly-
merisation within the host cell and the formation of a
pedestal, facilitating tighter adherence between the host
cell and the bacterium [17,23]. Other eukaryotic recep-
tors have been suggested for intimin, including nucleolin
and some b1 integrins, but as yet it is unknown if these
interactions have a role in vivo [24,25].
There is considerable sequence variation between the
intimins from different E. coli strains and they have been
categorised into different subtypes, each with a high affi-
nity for its own cognate Tir [26]. However, despite this
diversity, it has been found that within the C-terminal
binding domain there are four tryptophan residues and
two cysteine residues, which are conserved between all
subtypes [27,28]. The two cysteines are also conserved in
similar locations within the Y. pseudotuberculosis invasin.
In both invasin and intimin a disulphide bond is formed,
which is essential for the structure of the C-terminal
binding domain and therefore required for full function-
ality [29,30]. In the instance of invasin, disruption of
either cysteine results in an inability to bind to integrin,
and therefore is defective for invasion [29].
Analysis of Y. pseudotuberculosis strain IP32953
sequence data identified a gene encoding a protein with
significant amino acid similarity to invasin and intimin,
which has not been previously investigated. We have
termed this protein Ifp (intimin family protein) and
intriguingly it has been mutated to a pseudogene in all
seven Y. pestis genomes sequenced to date. Examination
of the amino acid sequence of Ifp revealed that three of
the four tryptophans and both of the cysteine residues
that are important in intimin function are conserved.
However, no Tir orthologue can be identified in the
IP32953 genome sequence. Given the amino acid simi-
larity of Ifp to both invasin and intimin, coupled with it
being putatively non-functional in Y. pestis,w ep o s t u -
lated that Ifp may be an adhesin. We demonstrate that
Ifp is a functional adhesin that binds to distinct foci on
host cells. Expression occurs in late log or early station-
ary phase at 37°C only and coincides with a decline in
the expression of invasin at this temperature.
Methods
Strains used and culture conditions
All Y. pseudotuberculosis strains were cultured in Luria-
Bertani (LB) broth Miller (BD Biosciences, Oxford, UK)
or on LB agar (Novagen, Nottingham, UK) at 28°C unless
otherwise stated. The retention of the virulence plasmid
(pYV) was screened by plating Y. pseudotuberculosis
strains on CRMOX plates [31]. Antibiotics were used at
the following concentrations where appropriate, ampicil-
lin (100 μgm l
-1), kanamycin (50 μgm l
-1), chlorampheni-
col (30 μgm l
-1) and trimethoprim (100 μgm l
-1). E. coli
strains were cultured at 37°C overnight in LB broth
Miller or on LB agar unless otherwise stated. See table 1
for a list of the strains and plasmids used in this study.
Construction of lux reporter strains
PCR primers (Table 2) were designed to amplify 956 bp
and 636 bp fragments between YPTB1572 and
YPTB1573 and between YPTB1667 and YPTB1668
respectively using Y. pseudotuberculosis strain IP32953
genomic DNA as a template. These regions contain the
putative promoter and regulatory sequences for ifp
(YPTB1572)a n dinv (YPTB1668). These PCR products
were cloned into the pGEM-T Easy vector (Promega,
Southampton, UK). KpnIa n dSpeI restriction sites had
Table 1 The strains and plasmids used in this study
Strain or plasmid Reference
Y. pseudotuberculosis IP32953 [3]
Y. pseudotuberculosis IP32953 ΔIFP This study
Y. pseudotuberculosis IP32953 ΔINV This study
Y. pseudotuberculosis IP32953 ΔIFPΔINV This study
Y. pseudotuberculosis IP32953 ΔIFPpIFP This study
Y. pseudotuberculosis IP32953 YPTB1572Lux This study
Y. pseudotuberculosis IP32953 YPTB1668Lux This study
E. coli TB1 MBP-Ifp This study
E. coli TB1 MBP-IfpC337G This study
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the luxCDABE operon from pBluelux [32] to be inserted
downstream of each promoter region. The entire pro-
moter-lux construct was excised from pGEM-T Easy
then re-cloned into the pDM4 suicide plasmid using
Transformax EC100D pir+ E. coli (Epicentre Biotechnol-
ogies, Madison, USA) for selection and screening. The
resulting promoter fusions 1572lux and 1668lux in
pDM4 were then electroporated into the IP32953 strain
of Y. pseudotuberculosis and screened for single cross-
over event into the genome by chloramphenicol resis-
tance. This crossover event resulted in a functional gene
of interest, with the lux cassette with native promoter
inserted upstream of the gene on the chromosome.
Bioluminescence and optical density of Lux constructs
Bioluminescence and optical density were monitored
simultaneously in 96-well microtitre plates using the
Anthos Lucy1 combined photometer and luminometer
controlled by the Stingray software (Dazdaq). Overnight
30°C cultures of 1572lux and 1668lux were diluted 1:200
in fresh LB with antibiotics and grown for 3-4 h at 30°C.
The optical density of the culture was adjusted to a start-
ing OD600 of 0.1 and 200 μl was added to the wells of the
96 well plate. Assays were performed at 24°C, 28°C and
37°C. Luminescence and OD at 405 nm of the cultures
was automatically determined every 30 min for 18 h and
presented as relative light units per unit of OD405 (light
per unit cell). For every promoter fusion assay each sam-
ple was assayed in triplicate on the 96-well plate, and
each experiment was carried out in duplicate.
Construction of Maltose Binding Protein (MBP) fusion
proteins
Primers YptbIntMBP-1 and YptbIntMBP-2 (Table 2)
were used to PCR amplify the 3’ end (1044 bp) of the
ifp coding sequence. This PCR product was cloned into
the pMAL-p2x vector (NEB, Hitchin, UK) using EcoRI
and XbaI enzyme restriction sites which had been incor-
porated into the primer design. In order to generate an
MBP-Ifp fusion with the terminal cysteine (Cys1070)
mutated to a glycine (MBP-IfpC337G), primer Ypt-
bIntMBP-3 was substituted for YptbMBP-2. Primer Ypt-
bIntMBP-3 contained an alternative sequence
(underlined in table 2) to mutate the terminal cysteine
to a glycine. MBP-fusion proteins were then expressed
in TB1 E. coli.
Purification of MBP-Ifp and MBP-IfpC337G
E. coli transformed with the MBP-fusion plasmids were
cultured for 2 h at 37°C using 5 ml of an overnight cul-
ture in 250 ml LB broth with 2 mM glucose and ampi-
cillin until a culture growth of OD600 0.5 was reached.
Expression of the fusion protein was induced with 0.3
mM isopropyl-b-D-thiogalactoside (IPTG) then the cul-
ture was incubated for further 2 hours at 37°C. The cul-
tures were centrifuged and pellets stored overnight at
-20°C then resuspended in column buffer (20 mM Tris-
HCl, 200 mM NaCl, 1 mM EDTA in H2O). The cells
were lysed by sonication using a Bioruptor sonicator
(Diagenode; 60 second pulses with a 30 second recovery
period). Insoluble proteins were removed by centrifuga-
tion and the supernatant was applied to 1 ml columns
of amylose resin (NEB). After washing with 15 ml col-
umn buffer, proteins were eluted with 10 ml column
buffer/10 mM maltose. Proteins were concentrated
using Amicon ultra 50 kDa columns (Millipore, Wat-
ford, UK), and then confirmed by Coomassie staining
and western blotting with anti-MBP (NEB). Protein con-
centrations were determined by Pierce BCA protein
assay kit (Rockford, USA) according to the manufac-
turer’s protocol.
Table 2 Primers used in this study
Primer Sequence
YPTB1572Lux1 TTTCCCGGGCACCTTGGCTGCACCGACTTC
YPTB1572Lux2 TTTGGTACCCGATAGAGACTCATACTTACC
YPTB1668Lux1 TTTCCCGGGCATTTTGGGTGAACACAGAGG
YPTB1668Lux2 TTTGGTACCGAGAAACTCACTGATTGGCTG
YptbIntMBP-1 TCAGAATTCATTAGTGAAGTCACCCCAAC
YptbIntMBP-2 TCATCTAGATGTGCCAGAGCCCTCCTAACC
YptbIntMBP-3 TCATCTAGATTTATTTTATACCCATGTAAAGC
INTPROM3 TTTGGTACCTCAATTACATATCGTTAACGC
INTPROM4 TTTGCATGCGATCTGTCTAAAGAGCGTCG
INTA TTTGCATGCTGGAGTATAGGTAAGTATGAG
INTB TTTGAGCTCGTTTGCACATCGGCTAATGG
YPTB1668Chlor1 CAGGTCCAGCCTTATTCTGTCTCTTCATCTGCATTTGAAAATCTCCATCCTCACTTATTCAGGCGTAGCAC
YPTB1668Chlor4 CGTTCTCCAATGTACGTATCCCGACGCCAAGGTTAAGTGTGTTGCGGCTGCATAGTAAGCCAGTATACACTC
Restriction sites are in bold and position of mutated cysteine to glycine residue is underlined.
Strong et al. BMC Microbiology 2011, 11:85
http://www.biomedcentral.com/1471-2180/11/85
Page 3 of 16Analysis of MBP-fusion protein binding to HEp-2 cells by
fluorescence microscopy
Binding of MBP-tagged Ifp was determined by fluores-
cence microscopy as described previously [18]. HEp-2
cells were cultured overnight on glass coverslips in 24-
well plates at 2.5 × 10
5 cells/well in 1 ml tissue culture
media (minimum essential medium eagle (MEM), 10%
fetal calf serum (w/v), 2 mM L-glutamine, 100 U peni-
cillin ml
-1,1 0 0μg streptomycin ml
-1, MEM non-essen-
tial amino acids). The cells were blocked for 30
minutes at 37°C/5% CO2 in 250 μl binding solution
(0.4% BSA (w/v), 2.5 mM maltose, 2 mM L-glutamine
in RPMI media), then incubated for 45 minutes at 37°
C/5% CO2 with 250 μl MBP-Ifp, MBP-IfpC337G or
MBP protein alone (NEB) at 100 μgm l
-1 in binding
solution. The cells were washed 5 times with 1 ml
PBS/1% BSA (w/v) and incubated for 30 minutes at
37°C/5% CO2 in 250 μl of a 1:1000 dilution of rabbit
anti-MBP antibody (NEB) in binding solution used.
Cells were washed 5 times with 1 ml PBS/1% BSA (w/
v) and incubated for 30 minutes at 37°C/5% CO2 in
250 μl of a 1:1000 dilution of goat anti-rabbit IgG
Alexafluor 488 (Invitrogen) in binding solution. Cells
were washed 4 times with 1 ml PBS/1% BSA (w/v) and
fixed for 15 minutes at -20°C in 250 μl of 95% etha-
nol-5% acetic acid (v/v). The cover slips were removed
from the wells, washed in Milli Q H2Oa n dm o u n t e d
onto glass slides with Vectashield-DAPI (Vector
Laboratories, Peterborough, UK) mounting medium.
The coverslips were examined using an Axiovert 200M
(Zeiss, Welwyn Garden City, UK) confocal microscope.
Experiment was performed on three independent occa-
sions and at least 50 cells were examined per
experiment.
FACScan analysis of MBP-fusion protein binding to HEp-2
cells
A similar methodology was used as for the fluorescence
microscopy as described previously [18], with the fol-
lowing modifications. The cells were grown directly in
6-well plates at 7 × 10
5 cells/well. The Alexafluor 488
anti-rabbit IgG antibody was diluted to 1:5000 in PBS/
1% BSA (w/v). Cells were resuspended in PBS/0.5%
EDTA (w/v) and transferred to BD Falcon 5 ml tubes
(VWR, Lutterworth, UK). Cells were washed once with
PBS/1% BSA (w/v) and centrifuged, then were fixed for
5 minutes on ice in 2% paraformaldehyde/PBS (w/v).
The cells were washed once with PBS/1% BSA (w/v),
centrifuged and then were resuspended in 500 μlP B S /
1% BSA/0.02% EDTA (w/v). The fluorescence was mea-
sured using a FACScan machine (Becton Dickinson,
Oxford, UK). Experiment was performed on two inde-
pendent occasions and 20,000 cells were examined for
fluorescence from each sample.
Analysis of co-localisation of MBP-fusion protein and the
receptors CD59 and b1 integrin on HEp-2 cells by
fluorescence microscopy
A similar methodology was used as for the fluorescence
microscopy described above with the following modifi-
cations. After the MBP-fusion protein incubation the
cells were washed 5 times with PBS then incubated with
250 μl of a 1:20 dilution rabbit anti-Ifp (CovalAb, this
study) and 1:1000 dilution of mouse anti-CD59 (Invitro-
gen) or a 1:1000 dilution of mouse anti-b1i n t e g r i ni n
binding solution for 30 minutes at 37°C/5% CO2.T h e
cells were washed 5 times with 1 ml PBS then incubated
with 250 μl of a 1:1000 dilution of goat anti-rabbit IgG
Alexafluor 594 (Invitrogen) and 1:1000 dilution of goat
anti-mouse IgG Alexafluor 488 (Invitrogen) for 30 min-
utes at 37°C/5% CO2. The cells were washed 5 times
with 1 ml PBS then fixed for 30 minutes at 4°C with
250 μl 2% paraformaldehyde (w/v). The coverslips were
removed from the wells, washed with PBS then
mounted onto glass slides with Vectashield-DAPI
mounting medium (Vector Laboratories). The slides
were examined using an Axiovert 200 M confocal
microscope (Zeiss). At least three areas of approximately
10 cells each were examined per sample and the experi-
ment was performed on three independent occasions.
Construction of ifp and inv insertional mutants
An ifp knockout mutant was generated in the Y. pseudo-
tuberculosis strain IP32953, after initially constructing an
ifp mutant in strain YPIII. Briefly, 1725 bp of ifp was
amplified with IntA and IntB primers, digested with
SacIa n dSphI then ligated into the cloning vector
pGEM-T easy. The plasmid was digested with BglII to
linearise and allow for the ligation of the kanamycin cas-
sette within the ifp sequence. PCR with primers IntA
and IntB was undertaken on the plasmid to create linear
fragments of kanamycin cassette flanked by ifp
sequence. This PCR product was electroporated into
YPIII previously transformed with pKOBEG, which con-
tains the l red recombinase operon. The temperature
sensitive pKOBEG plasmid was then lost from putative
mutants by growth at 37°C, whilst the presence of the
pYV plasmid was maintained by the addition of 2.5 mM
CaCl2. Southern blot analysis confirmed correct muta-
tion. Genomic DNA from this YPIIIΔifp w a su s e da sa
template for PCR amplification of the kanamycin cas-
sette flanked by two ~500 bp regions of gene-specific
DNA. The primers INTA and INTB (Table 2) were
used to amplify a 2.7 kbp product. This was purified
using a Qiagen PCR purification kit, precipitated, and
then resuspended in 5 μl MilliQ H2O. Strain IP32953
containing the mutagenesis plasmid pAJD434 [33] was
grown in LB broth containing 100 μg trimethoprim ml
-1
and 0.8% arabinose (w/v) for 5 hours at 28°C in order to
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pAJD434 plasmid. These cells were electroporated with
the purified PCR product and kanamycin resistant
colonies were screened by PCR and Southern blot to
confirm the correct insertion. The pAJD434 plasmid
was then removed by incubation overnight at 37°C in
the presence of 2.5 mM CaCl2. Colonies were screened
to confirm the loss of the pAJD434 plasmid and the pre-
sence of the virulence plasmid (pYV). A similar method
was used for the construction of the inv mutant except
primers YPTB1668Chlor1 and YPTB1668Chlor4 (Table
2), were designed to amplify the chloramphenicol resis-
tant cassette from pBAD33 flanked by 50 bp gene-speci-
fic regions. This PCR product was then used as
described above to generate an insertional mutant of the
inv gene (IPΔINV) and a double ifp and inv insertional
mutant (IPΔIFPΔINV), by electroporation into IP32953
WT or mutated ifp (IPΔIFP) strains. Colonies were
screened as above with inv specific primers and the pre-
sence of pYV and loss of pAJD434 was confirmed.
Construction of ifp complement in pBAD33 plasmid
The ifp gene including native promoter was amplified by
PCR using specific primers INTPROM3 + INTPROM4
(Table 2). After ligation into pGEM-T Easy vector (Pro-
mega) the construct was transformed into XL2-Blue E.
coli (Stratagene, La Jolla, USA). The construct was
screened by PCR and sequenced, before the ifp gene
with promoter was digested from the pGEM-T Easy
vector with KpnI and SphI and purified by gel extraction
using a Gen Elute purification kit (Sigma). This insert
was cloned into a pBAD33 plasmid [34], also digested
with KpnI and SphI and transformed into TOP10 E. coli
(Invitrogen). These colonies were again screened by
PCR and by digestion with EcoRV to confirm the cor-
rect insert and orientation within the pBAD33 vector.
IPΔIFP cells were made competent by washing 3 times
in 10 ml ice cold H2O and electroporated with pBA-
D33ifp (pIFP) plasmid to generate an ifp mutant with a
complemented ifp gene (IPΔIFPpIFP). These were
screened by PCR and were DNA sequenced again to
confirm the presence of the correct complemented gene.
Plasmid cured strains
Wild type, defined mutants and ifp complemented
mutant strains lacking the pYV plasmid were generated
by culturing strains overnight at 37°C the selecting for
white colonies on CRMOX plates [31]. Loss of pYV was
verified by PCR and repeated screening on CRMOX.
Adhesion and invasion of HEp-2 cells
HEp-2 cells were cultured overnight at 37°C 5% CO2 on
coverslips in 24-well plates at 2 × 10
5 cells/well in 1 ml
tissue culture medium. The 10 ml LB broth cultures of
IP32953 wild type (IPWT), defined mutants (IPΔIFP,
IPΔINV, IPΔIFPΔINV) and mutant with complemented
ifp (IPΔIFPpIFP), were incubated at 37°C for 14 hours
with appropriate antibiotics and 2.5 mM CaCl2.T h e
cells were washed 3 times with 1 ml PBS and then, at a
multiplicity of infection (MOI) of 70:1, incubated for
1 hour with 1 ml of bacterial culture in MEM media at
37°C, 5% CO2. Inoculum was plated on LB agar to
determine number of colony forming units (cfu). The
cells were washed 5 times with 1 ml PBS and then fixed
with 2% paraformaldehyde (w/v) for 45 minutes at 4°C,
before being washed again 5 times with 1 ml PBS. The
coverslips were incubated with a 1:500 dilution of anti-
Yersinia pseudotuberculosis antibody (Abcam, Cam-
bridge, UK) in PBS for 45 minutes at room temperature.
The coverslips were washed with PBS then incubated
with a 1:1000 dilution of anti-rabbit IgG Alexafluor 488
(green) (Invitrogen) in PBS for 45 minutes at room tem-
perature. After washing with PBS the cells were permea-
bilised with 0.1% Triton X100-PBS (v/v) for 20 minutes
at room temperature. The coverslips were washed with
PBS and incubated with 1:500 dilution of anti-Y. pseudo-
tuberculosis antibody (Abcam) in PBS for 45 minutes at
room temperature, before being washed again with PBS.
Anti-rabbit IgG Alexafluor 594 (red) (Invitrogen) was
diluted 1:1000 in PBS and the coverslips were incubated
for 45 minutes at room temperature. The coverslips
were washed with PBS and mounted onto slides with
Vectorshield-DAPI mounting media (Vector Labora-
tories). Slides were examined by Axiovert 200 M (Zeiss)
confocal microscope. Three coverslips per strain with
100 HEp-2 cells per coverslip were counted, utilising the
z stack images to gain a 3D representation of the cell.
Adhesion and invasion were quantified by counting
invaded (red) and adhered (red/green) bacteria and cal-
culating percentage adhesion or invasion per HEp-2 cell
based on known MOI. This adhesion and invasion assay
was performed on at least three independent occasions.
Detection of the presence of invasin by western blot
Strains were cultured for 15 hours at 28°C and 37°C, the
OD600 nm measured and cultures adjusted so all strains
had equal quantities of bacteria/ml. Strains were run on
a SDS-PAGE 12% Bis-Tris gel, blotted onto nitrocellu-
lose membrane and blocked with 5% milk-PBS-0.1%
Tween20. Invasin was visualised by staining with anti-
invasin monoclonal antibody [35] at 1:10000 and anti-
rabbit IgG peroxidase conjugate (Sigma) secondary anti-
body at 1:10000.
Galleria mellonella model of infection
G. mellonella larvae were purchased from Livefood UK
Ltd (Rooks Bridge, Somerset, UK). Larvae were infected
with 10
6 cfu Y. pseudotuberculosis IP32953WT, IPΔIFP,
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by micro-injection (25 μl Hamilton syringe, Cole Pal-
mer, London, UK) in the right foremost leg. PBS and no
injection controls were used. The larvae were incubated
at 37°C and survival at 72 hours post-infection was
recorded. Larvae were scored as dead when the coloura-
tion changed from normal pale cream to brown and
failed to respond even after gentle manipulation with a
pipette tip.
Results
Identification of an intimin and invasin-like protein in Y.
pseudotuberculosis
T h eg e n o m es e q u e n c eo fY. pestis strain CO92 first
revealed the potential presence of an intimin-like protein
[36]. However, in this sequence and all other subsequently
sequenced Y. pestis strains, the predicted coding sequence
for the intimin-like protein is disrupted by an IS285 ele-
ment, or in the instance of strain 91001, a premature stop
codon. By contrast, this gene is intact in all four Y. pseudo-
tuberculosis strains sequenced to date, with at maximum,
only six amino acid differences between these strains
(Additional file 1). Alignments with the European Bioin-
formatics Institute (EBI) EMBOSS Pairwise Alignment
tool [37] revealed that the translated full-length coding
sequence of IP32953 Ifp has 33.9% amino acid identity (or
46.7% similarity) to Y. pseudotuberculosis IP32953 invasin,
and 29.7% amino acid identity (42.8% similarity) to the a-
subtype of intimin (eaeA) from E2348/69 E. coli, therefore
this gene was termed ifp. Using the ClustalW program
(SDSC Workbench, San Diego, USA) alignment of the C
terminal domains of invasin, intimin and Ifp, reveals the
presence of two cysteine residues in Ifp, which are impor-
tant for the function of invasin and intimin (Figure 1). In
addition three of the four tryptophans, which are present
in all intimin subtypes [27], are also present in Ifp and
invasin (Figure 1).
Thermoregulated temporal expression of ifp and inv
The expression of ifp (YPTB1572)a n dinv (YPTB1668)
at 24°C, 28°C and 37°C, were monitored using lux-based
promoter fusions 1572lux and 1668lux in Y. pseudotu-
berculosis IP32953, with the resultant luminescence read
in a Lucy1 combined photometer and luminometer (Fig-
ure 2). The expression was determined as relative light
units/optical density (RLU/OD) therefore the growth
phase could also be determined, based on these OD
readings (Additional file 2). Inv was maximally expressed
during log phase after 5 hours at 24°C and 28°C, but
after only 2.5 hours at 37°C, suggesting that mammalian
body temperature is important in the induction of inv
and confirms the observation of Isberg et al. [38]. In
contrast, ifp expression remains low at 24°C and 28°C
throughout the time course, whereas at 37°C there was
little expression in first 7.5 hours, after which expression
increases to a peak at 13 hours (Figure 2).
Ifp binds to localised foci on HEp-2 cells
Invasin and intimin are able to bind directly to specific
receptors on the surface of mammalian cells. We there-
fore investigated the ability of Ifp to bind directly to
HEp-2 cells using a MBP tagged Ifp purified protein
(MBP-Ifp). In addition, to determine if the terminal
cysteine was as important in Ifp functionality (as it is in
invasin and intimin), a MBP-Ifp recombinant protein
with the terminal cysteine mutated to a glycine (MBP-
IfpC337G) was constructed and tested. Utilising flow
cytometry, FACScan analysis showed a shift in the peak
of fluorescence of HEp-2 cells which had been incu-
bated with MBP-Ifp (Figure 3). This shift was not seen
with cells incubated with MBP-IfpC337G or MBP alone,
indicating not only that this is a specific binding of
MBP-Ifp, but also that the terminal cysteine is impor-
tant in the functional binding of Ifp to HEp-2 cells.
However, MBP-Ifp only appears to bind to a subset of
cells and to differing levels, as shown by the width of
the shifted peak. In order to investigate this further, we
used confocal microscopy to visualise the binding of
MBP-Ifp to HEp-2 cells (Figure 4). Again no specific
binding is seen with the MBP control and binding is
greatly reduced with MBP-IfpC337G, whilst the MBP-Ifp
fusion protein binds to individual cells with significant
levels of fluorescence visible. Of 50 cells examined ~40%
showed MBP-Ifp adherence, with only ~15% showing
MBP-IfpC337G adhesion. Of those showing MBP-IfpC337G
adherence, fewer fluorescing spots were observed per
cell compared to MBP-Ifp, and these spots were smaller.
Interestingly, this binding appears to be localised to
specific foci on the cell surface, rather than a random
scattering of fluorescence across the entire cell surface.
This suggests that the protein is binding to specific
receptors on the cell surface which are localised in foci.
In order to investigate if a putative receptor was loca-
lised in cholesterol and sphingolipid-enriched plasma
membrane micro-domains (lipid rafts), we used co-loca-
lisation assays. In this instance the GPI-anchored pro-
tein CD59, which is known to localise to these
microdomains [39], was used as a marker for the posi-
tion of the lipid rafts. Confocal microscopy revealed that
there is co-localisation between CD59 and MBP-Ifp
bound on the cell surface, indicating that there is a
putative receptor for Ifp present within these lipid rafts
(Figure 5A). However, as there is binding of MBP-Ifp
which does not co-localise, and as invasin is known to
bind to b1 integrin, co-localisation between MBP-Ifp
and b1 integrin was also investigated (Figure 5B). No
co-localisation was observed between MBP-Ifp and b1
integrin.
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In order to confirm the role of Ifp as an adhesin, we
constructed an insertion mutant in the ifp coding
sequence of Y. pseudotuberculosis strain IP32953
(IPΔIFP). For comparative purposes, we also con-
structed an insertion mutant in the inv gene (IPΔINV),
and a double insertion mutant (IPΔIFPΔINV) in the
same strain. To determine the level of adhesion and
invasion of these defined mutants, in comparison to
wild type, a differential staining assay [40] was utilised.
Figure 6 shows that there is a significant decrease in
the level of adhesion of IPΔIFP compared to wild type
(IPWT), which could be restored by complementation
with the wild type ifp gene (IPΔIFPpIFP) (Figure 6A).
The inv mutant did not show as great a reduction in
adhesion as IPΔIFP, but the double mutant showed
comparable levels to the ifp single mutant. A signifi-
cant decrease in invasion of IPΔIFP compared to wild
type is observed (Figure 6B). Both IPΔINV and
IPΔIFPΔINV show significant decreases in invasion
compared to wild type; however, it was beyond the
sensitivity of this assay to determine slight differences
between these two strains. The average ratio of intra-
cellular:extracellular bacteria for each of the strains
associated with the HEp-2 cells was as follows; IPWT
1:8; IPΔIFP 1:8; IPΔINV 1:176; IPΔIFPΔINV 1:141 and
IPΔI F P p I F P1 : 8 .T od e t e r m i n et h er o l eo ft h ev i r u l e n c e
factors of the pYV in the adhesion and invasion still
seen in these assays, the strains were cured of the pYV
plasmid and the differential staining assay repeated
(Figure 6C). Invasion levels were all below the sensitiv-
ity of this assay, but a significant difference was
observed between wild type and IPΔIFP, IPΔINV and
IPΔIFPΔINV for adhesion. Although the expression
analysis suggested the invasin should not be expressed
at the time point used for these experiments, as there
was a significant difference between wild type and inv
mutants, presence of invasin was examined by western
Figure 1 Amino acid alignment of intimin, ifp and invasion. The C-terminal 280 residues of EPEC 2348/69 intimin (Int280) and the
corresponding regions from Y. pseudotuberculosis IP32953 Ifp and invasin were aligned. Residues important in intimin function are shown:
conserved cysteine residues are highlighted in light grey whilst tryptophan residues are highlighted in dark grey.
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Page 7 of 16blot (Figure 6D). Invasin was found to still be present
at 37°C although at a reduced level compared to 28°C
15 hour cultures. No invasin was observed in IPΔINV
and IPΔIFPΔINV which confirms the mutation of the
inv gene in these strains.
Galleria model of infection
Galleria mellonella h a sb e e nu s e da sa ni n f e c t i o nm o d e lf o r
several bacterial pathogens because it possesses an innate
immune system with structural and functional homology
to the mammalian immune system. Consequently it can be



Figure 2 Temporal expression of ifp (1572lux)a n dinv (1668lux). Expression was determined by light emission from lux-reporter strains
grown at (A) 24°C, (B) 28°C and (C) 37°C. Three biological replicates are shown for each strain, with each biological replicate tested in triplicate.
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Page 8 of 16utilised as a less labour intensive and more cost effective
model, in comparison to the traditional murine model of
in vivo infection [41]. This model has been used recently
for infection studies with Y. pseudotuberculosis [42]. There-
fore, in addition to the adhesion and invasion assays, the
ability of the mutants to infect and kill the wax moth larvae
G. mellonella was examined. Bacteria, which had been cul-
tured overnight at 37°C, were injected into the foreleg of
the G. mellonella at 10
6 colony forming units (cfu) per 10
μl injection. After 72 hours at 37°C the number of dead G.
mellonella were enumerated (Figure 7); larvae were scored
as dead if they had become melanised and ceased moving
[42]. Both IPΔIFP (average 58% survival, p = 0.057) and
IPΔINV (average 48% survival, p = 0.200) mutants showed
modest if not significant attenuation in the G. mellonella
model, compared to wild type IP32953 (average 30% survi-
val). IPΔIFPpIFP shows similar levels of virulence to IPWT
(average 30% survival, p = 0.857). Average survival of 75%
was recorded in larvae infected with the double mutant,
which showed a significant difference to the wild type (p =
0.028) when analysed by non-parametric t-test (Graphpad
P r i s m4 ,L aJ o l l a ,U S A ) .
Discussion
In this study we investigated the role of a novel Y. pseu-
dotuberculosis adhesin (Ifp), which shows similarity to
both invasin and the intimin adhesin of EPEC and
EHEC (Figure 1). As invasin and intimin are well char-
acterised virulence determinants, the discovery of a new
member in the same family of outer membrane

 

Figure 3 FACScan analysis of the binding of purified MBP-fusion proteins to HEp-2 cells. Cells were incubated with (A) MBP-Ifp, (B) MBP-
IfpC337G, (C) MBP or (D) PBS and binding was visualised with anti-MBP and anti-rabbit Alexafluor 488 antibodies.
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Page 9 of 16adhesins, is intriguing. The predicted coding sequence
for ifp is disrupted in all seven currently sequenced
strains of Y. pestis, although it is intact in the four Y.
pseudotuberculosis strains sequenced. This disruption is
due to an insertion element (IS285) in all Y. pestis
strains, with the exception of the atypical 91001 Y. pestis
Microtus strain, where it is disrupted by a nonsense
mutation [3,43,44]. This may suggest that the disruption
in this gene in Y. pestis occurred early in the divergence
of Y. pestis from Y. pseudotuberculosis and may have
been a potentially important step in this evolutionary
process. The inv gene of Y. pseudotuberculosis is also
disrupted by an insertion element (IS200) in Y. pestis
[45]. The reason for the loss of function of invasin and
Ifp in Y. pestis is unknown, but given that it does not
have an enteric phase in its lifecycle, it is likely to be
not required. This follows the “use it or lose it” concept,
whereby genes which no longer provide a selective
advantage to the bacteria become pseudogenes [46]. The
amino acid similarity of Ifp to both invasin and intimin,
coupled with its retention in Y. pseudotuberculosis, sug-
gests a putative role for Ifp in adhesion to cells and that
Ifp is a new member in the family of surface adhesins
together with invasin and intimin.
Figure 4 Binding of purified MBP-fusion proteins to HEp-2 cells. Cells were incubated with (A) MBP-Ifp, (B) MBP-IfpC337G, (C) MBP or (D) PBS
and binding was visualised with anti-MBP and anti-rabbit Alexafluor 488 antibodies. Representative cells are shown and the 10 μm ruler is
shown in red.
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Page 10 of 16The C-terminal 280 amino acids of intimin are the
functional domain in this adhesin [28], and two
cysteine (C859 and C937; numbering according to
EPEC strain E2348/69) and four tryptophan (W776,
W795, W881 and W899) residues are conserved
between all intimin subtypes. An alignment of the C-
terminal region amino acid sequences of a-subtype
intimin from EPEC, Y. pseudotuberculosis invasin and
Ifp, revealed that both cysteine and three out of the
four tryptophan residues were found to be conserved
DWͲ/ĨƉϯϯϳ'
DWͲ/ĨƉ
DWͲ/ĨƉϯϯϳ'


DWͲ/ĨƉ
Figure 5 Fluorescence microscopy showing co-localisation of (A) CD59 and (B) b1 integrin with purified MBP-fusion proteins on HEp-2
cells. Cells were incubated with MBP-Ifp or MBP-IfpC337G. MBP-fusion proteins were visualised with anti-Ifp and anti-rabbit Alexafluor 594
antibodies. CD59 was visualised with anti-CD59 and anti-mouse Alexafluor 488 antibodies. b1 integrin was visualised with anti-b1 integrin and
anti-mouse Alexafluor 488 antibodies. Representative cells are shown.
Strong et al. BMC Microbiology 2011, 11:85
http://www.biomedcentral.com/1471-2180/11/85
Page 11 of 16in both Ifp and invasin (Figure 1). Only W776 was not
conserved in Ifp and invasin. These cysteine and tryp-
tophan residues are involved in receptor binding by
intimin [27,30] and therefore may have a role in Ifp
receptor binding.
We demonstrated direct binding of Ifp using both
flow cytometry and fluorescence microscopy, where the
MBP-Ifp fusion proteins could bind to HEp-2 cells. By
contrast the MBP alone did not bind and the specific
cysteine residue mutant MBP-IfpC337G showed greatly
reduced levels of binding (Figures 3 and 4). This
reduced level of binding with the MBP-IfpC337G shows
that the cysteine residue is important to allow Ifp bind-
ing. The same cysteine residue is known to be important
in both intimin and invasin, through the formation of a
disulphide bond [18,29], therefore it may be that the
cysteine has a similar role in Ifp. The width of the
FACS fluorescence intensity graph suggests that MBP-
Ifp does not bind uniformly to all cells (Figure 3). This
was confirmed by confocal microscopy, where the cells
which were exposed to the MBP-Ifp fusion protein,
showed a pattern of fluorescence of intensely stained
localised areas, instead of scattered fluorescence across
the cell surface. A similar pattern of adherence was
observed when HEp-2 cells were incubated with MBP
fusion proteins of intimin and invasin [18]. As invasin is
known to bind to b1 integrins and it has been suggested
that intimin can bind to b1 integrin [13,24,25] co-locali-
sation of Ifp to b1 integrin was investigated (Figure 5B).
As no co-localisation was observed it shows that Ifp
binds to alternative receptors on the cell surface. Lipid
rafts are sphingolipid and cholesterol rich regions of the
plasma membrane, into which Tir is thought to be
transferred [47,48]. Additionally uropathogenic E. coli
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Figure 6 Adhesion and invasion of HEp-2 cells by wild type IP32953 and defined mutants. (A) adhesion, (B) invasion (C) adhesion with
pYV cured strains, using differential staining assay. Wild type (IPWT) was compared to insertional mutants of ifp (IPΔIFP) and inv (IPΔINV), an ifp
and inv double mutant (IPΔIFPΔINV) and an ifp mutant with complemented ifp (IPΔIFPpIFP), by setting IPWT values to 100%. Strains cured of pYV
are marked with “c”. Data was pooled from assays performed in triplicate on at least three independent occasions with statistical analysis by
unpaired t-test and statistically significant results designated by *. ** indicates p value of <0.005, *** indicates p value of <0.0005. (D) Presence of
invasin at 28°C and 37°C after 15 hours incubation detected by western blotting with anti-invasin monoclonal antibody.
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Page 12 of 16are known to invade via lipid rafts [49], and Salmonella
and Shigella sp. use a type three secretion system to
translocate effectors, by binding to cholesterol within
lipid rafts [50]. To investigate if MBP-Ifp was binding to
a component of these lipid rafts, co-localisation of
MBP-Ifp to CD59 was undertaken by confocal micro-
scopy. CD59 was selected as it is known to localise to
these micro-domains and could therefore act as a mar-
ker. The results show co-localisation of Ifp and CD59,
which was reduced with MBP-IfpC337G (Figure 5A), sug-
gesting that there is a putative receptor for Ifp within
these lipid rafts. The Ifp receptor within these lipid rafts
has yet to be determined, but as not all of the MBP-Ifp
co-localised, no conclusions can currently be made as to
the exact receptor of Ifp.
Inv is differentially thermoregulated with lower
levels being expressed at 37°C compared to 28°C [38].
In comparison, yadA shows maximal expression at 37°
C in exponential phase culture, conditions where inv
expression is repressed [51]. YadA is a virulence plas-
mid (pYV) encoded adhesin, known to be involved
during the infection of Y. pseudotuberculosis [51-53].
The pattern of inv expression was confirmed by this
study, where inv was expressed both at 28°C and 37°C
during lag and early log phase culture, although at a
greater degree at 28°C (Figure 2). The ifp gene appears
to be expressed at 37°C at a later time point in the
late log or early stationary phase, when inv expression
is reduced. As ifp and yadA are expressed at similar
time points and at the same temperature, Ifp may
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Figure 7 Survival of G. mellonella following infection with 10
6 cfu per larva of Y. pseudotuberculosis wild type IP32953 and defined
mutants. Wild type (IPWT) was compared to insertional mutants of ifp (IPΔIFP) and inv (IPΔINV), an ifp and inv double mutant (IPΔIFPΔINV) and
an ifp mutant with complemented ifp (IPΔIFPpIFP). Phosphate buffered saline (PBS) injection and uninfected (UI) Galleria were utilised as controls.
Assays were performed on at least three independent occasions, each with 10 larvae per strain. Statistical analysis by non-parametric t-test with
statistically significant results marked with * (p =< 0.05).
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Page 13 of 16have a similar role to YadA during the infection of Y.
pseudotuberculosis [51]. Although inv expression is
decreased at a later time point, it still appears to have
an effect on the invasion of Y. pseudotuberculosis (Fig-
ure 6B); this is despite using stationary phase cultures
which had been grown at 37°C. The western blot ana-
lysis for presence of invasin under these conditions
(Figure 6D), confirmed that although inv may no
longer be actively expressed, invasin was still present
in the cell and could therefore have a role in invasion
of HEp-2 cells.
The invasion and adhesion assays confirmed the
microscopy and flow cytometry results, in demonstrat-
ing a role for Ifp as an adhesin, as the levels of adhesion
were reduced with IPΔIFP in comparison to wild type
(Figure 6A). The inv mutant did not show as great a
decrease in adhesion as the ifp mutant, but the double
mutant showed similar if not a marginally greater reduc-
tion in adhesion as IPΔIFP, in comparison to the wild
type. Although levels of invasion were significantly
affected by IPΔIFP, this may be due to reduced adhe-
sion, suggesting that Ifp is an adhesin. Any differences
between IPΔINV and IPΔIFPΔINV were beyond the
detection capability of this assay, but it appeared that
invasin was the dominant protein involved in the inva-
sion of the HEp-2 cells. Removal of the pYV and there-
fore the YadA and Yop virulence factors allowed greater
distinction of the role of Ifp. Without these extra viru-
lence determinants compensating for the mutation of
ifp,t h eI P ΔIFP mutant showed a statistically significant
r e d u c t i o ni na d h e s i o nc o m p a r e dt oI P W T( F i g u r e6 C ) .
This confirms the role of Ifp as an adhesin of Y.
pseudotuberculosis.
As G. mellonella possesses an innate immune system
with structural and functional similarities to the mam-
malian innate immune system, it is a useful alternative
to the traditional murine yersiniosis infection model, to
examine virulence in vivo, especially as unlike the C. ele-
gans model, G. mellonella can be incubated at 37°C
[42,54]. Previous studies with Y. pseudotuberculosis
comparing G. mellonella and the murine model, showed
that G. mellonella could reflect infection in mammals
and therefore could be useful as a higher throughput
screen of mutants, before a more in depth analysis was
undertaken in the murine model [42]. In this study the
G. mellonella model demonstrated a role for Ifp in the
pathogenesis of Y. pseudotuberculosis, in particular in
concert with invasin, as the double mutant showed a
significant increase in survival compared to the wild
type (Figure 7). There also appeared to be mild attenua-
tion in virulence with both of the single mutants. This
suggests that Ifp, together with invasin, does have a role
in virulence of Y. pseudotuberculosis in this infection
model.
Conclusions
We have shown the presence of a novel functional adhe-
sin in Y. pseudotuberculosis that has been mutated with
an IS element and is presumably non-functional in
Y. pestis. Ifp is expressed during late log to early station-
ary phase at 37°C and demonstrates an ability to bind to
HEp-2 cells in vitro, which can be disrupted by muta-
t i o no ft h eg e n e ,o re v e nas i n g l ec y s t e i n er e s i d u e .
Together with invasin and intimin, Ifp is a new member
of a family of outer membrane adhesins that is activated
at 37°C and may act at a later stage than invasin during
infection.
Additional material
Additional file 1: Amino acid alignment of Ifp from the four
currently sequenced genomes of Y. pseudotuberculosis. Utilising the
ClustalW program, the amino acid sequences of Y. pseudotuberculosis
strains IP32953, IP31758, PB1 and YPIII were aligned.
Additional file 2: Growth curves from the temporal expression of
Ifp and invasin assay. Within the Anthos Lucy1 combined photometer
and luminometer, OD readings at 600 nm were taken at 30 minute
intervals and used to construct these growth curves. Cultures were
incubated at (A) 24°C (B) 28°C and (C) 37°C.
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